Form D — Hopewell Therapeutics, Inc.
0001836562-25-000003 · filed Sep 17, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $3,499,999
- Reported amount sold
- $2,499,999
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Hopewell Therapeutics, Inc.
- CIK
- 1836562
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 216 WEST CUMMINGS PARK
WOBURN, Massachusetts 01801 - Phone
- 617 921 7082
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Thomas V. Hennessey, III · DirectorWoburn, Massachusetts Find on LinkedIn ↗
-
Xutian Jing · DirectorWoburn, Massachusetts Find on LinkedIn ↗
-
Nan Shen · DirectorWoburn, Massachusetts Find on LinkedIn ↗
-
Xiaowen Femg · DirectorWoburn, Massachusetts Find on LinkedIn ↗
-
Qiaobing Xu · Executive OfficerWoburn, Massachusetts Find on LinkedIn ↗
-
C. Thomas Paschall · DirectorWoburn, Massachusetts Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗